MedPath

The Effects of Nitrate, Caffeine, and Cold Exposure on Cardiovascular Function.

Not Applicable
Active, not recruiting
Conditions
Nitrate
Caffeine
Cold Exposure
Interventions
Dietary Supplement: TruBeet inorganic beetroot juice
Dietary Supplement: Caffeine
Other: Cold pressor test
Registration Number
NCT06602921
Lead Sponsor
Loughborough University
Brief Summary

Dietary inorganic nitrate supplementation may have positive implications on cardiovascular function. The aim of this project is to determine if nitrate supplementation can attenuate the effects that caffeine and cold exposure have on the cardiovascular system.

Detailed Description

Acute caffeine consumption and cold exposure elicit negative effects on the cardiovascular system. Humans are regularly exposed to such conditions of increased cardiovascular strain, which may lead to elevated chronic cardiovascular risk. On the other hand, dietary inorganic nitrate supplementation is well established to improve cardiovascular function in healthy individuals. Thus, acute nitrate supplementation may compensate for the negative effects that caffeine and the cold place on the cardiovascular system. These effects will be measured using peripheral blood pressure, pulse wave analysis, heart rate variability, forearm blood flow, flow mediated dilation, and blood and saliva markers.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Blood pressure < 130 mmHg systolic and < 85 mmHg diastolic. BMI between 18.5 and 29.9 kg/m2. Females must be naturally menstruating (regular length cycle and menses) or using a form of combined hormonal contraception (for at least 6 months).
Exclusion Criteria
  • Existing cardiovascular or metabolic conditions. Experience any adverse reactions to experimental procedures or supplements. Allergies to supplements or breakfast items. Involved in any other studies. Blood pressure > 130 mmHg systolic and > 85 mmHg diastolic.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Nitrate, caffeine, and cold pressor test (CPT)TruBeet inorganic beetroot juiceAll outcome variables will be measured for 24 participants in a trial where they receive 400 mg nitrate in the form of beetroot extract, 6 mg/kg caffeine powder, and undergo a 3 min cold pressor test.
Nitrate, caffeine, and cold pressor test (CPT)CaffeineAll outcome variables will be measured for 24 participants in a trial where they receive 400 mg nitrate in the form of beetroot extract, 6 mg/kg caffeine powder, and undergo a 3 min cold pressor test.
Nitrate, caffeine, and cold pressor test (CPT)Cold pressor testAll outcome variables will be measured for 24 participants in a trial where they receive 400 mg nitrate in the form of beetroot extract, 6 mg/kg caffeine powder, and undergo a 3 min cold pressor test.
Nitrate, placebo caffeine, and CPTTruBeet inorganic beetroot juiceAll outcome variables will be measured for 24 participants in a trial where they receive 400 mg nitrate in the form of beetroot extract, 6 mg/kg cornflour (caffeine placebo), and undergo a 3 min cold pressor test.
Nitrate, placebo caffeine, and CPTCold pressor testAll outcome variables will be measured for 24 participants in a trial where they receive 400 mg nitrate in the form of beetroot extract, 6 mg/kg cornflour (caffeine placebo), and undergo a 3 min cold pressor test.
Placebo nitrate, caffeine, and CPTCaffeineAll outcome variables will be measured for 24 participants in a trial where they receive nitrate-depleted beetroot extract (placebo), 6 mg/kg caffeine powder, and undergo a 3 min cold pressor test.
Placebo nitrate, caffeine, and CPTCold pressor testAll outcome variables will be measured for 24 participants in a trial where they receive nitrate-depleted beetroot extract (placebo), 6 mg/kg caffeine powder, and undergo a 3 min cold pressor test.
Placebo nitrate, placebo caffeine, and CPTCold pressor testAll outcome variables will be measured for 24 participants in a trial where they receive nitrate-depleted beetroot extract (placebo), 6 mg/kg cornflour (caffeine placebo), and undergo a 3 min cold pressor test.
Primary Outcome Measures
NameTimeMethod
Brachial blood pressureMean of 5 readings taken pre-supplementation (0 hours) and post-supplementation (2.5 hours). 1 reading was taken pre- cold pressor test (3.5 hours). All measures were recorded on every experimental trial (4 trials with at least 48 h washout between).

Brachial blood pressure was collected using an automatic sphygmomanometer.

Flow mediated dilationMeasured pre-supplementation (at 0 hours) and post-supplementation (at 2.5 hours) for every experimental trial (4 trials with at least 48 h washout between).

Baseline diameter, peak diameter, change in diameter, and shear stimulus following flow mediated dilation procedure of the brachial artery with post-occlusion reactive hyperaemia.

Central blood pressure and pulse wave variablesCollected pre-supplementation (0 hours), post-supplementation (2.5 hours), and during the cold pressor test (3.5 h) for 4 experimental trials (4 trials with at least 48 hours washout in between).

Mean of 2-3 readings for aortic systolic BP, aortic diastolic BP, HR, Augmentation index, augmentation index corrected to HR of 75 bpm, pulse pressure, and augmentation pressure.

Secondary Outcome Measures
NameTimeMethod
Forearm blood flowMeasured pre-supplementation (at 0 hours) and post-supplementation (at 2.5 hours) for every experimental trial (4 trials with at least 48 h washout between).

Forearm blood flow pre- and post-PORH (post occlusion reactive hyperaemia) via strain gauge plethysmography.

Salivary nitrate and nitriteMeasured pre-supplementation (at 0 hours) and post-supplementation (at 2.5 hours) for every experimental trial (4 trials with at least 48 h washout between).

Salivary concentration of nitrate and nitrite

Heart rate variabilityCollected pre-supplementation (0 hours), post-supplementation (2.5 hours), and during the cold pressor test (3.5 h) for 4 experimental trials (4 trials with at least 48 hours washout in between).

Time and frequency domains for heart rate variability collected for 3-5min.

NIBP continuous blood pressureCollected pre-supplementation (0 hours), post-supplementation (2.5 hours), and during the cold pressor test (3.5 h) for 4 experimental trials (4 trials with at least 48 hours washout in between).

SBP, DBP, MAP, HR collected continuously for 3-5 min.

Whole blood RSNOCollected pre-supplementation (0 hours), post-supplementation (2.5 hours), and immediately post- cold pressor test (3.5 h) for 4 experimental trials (4 trials with at least 48 hours washout in between).

S--nitrosothiols concentration from treated whole blood (NEM, EDTA, potassium ferricyanide).

Plasma nitrate, nitrite, cGMPCollected pre-supplementation (0 hours), post-supplementation (2.5 hours), and immediately post- cold pressor test (3.5 h) for 4 experimental trials (4 trials with at least 48 hours washout in between)

Plasma concentrations of nitrate, nitrite, and cGMP.

Trial Locations

Locations (1)

Loughborough University

🇬🇧

Loughborough, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath